Minimal increases in levels of HER2 allow for the altered growth of mammary glands [4], setting the stage for early breast lesions, leading to ductal carcinoma in situ (DCIS) [5,6]. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.